Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
about
A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.Novel oral anticoagulants for heparin-induced thrombocytopenia.Suspected Heparin-Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation.Monitoring of Argatroban and Lepirudin.Biosimilars of low-molecular-weight heparin products: fostering competition or reducing 'biodiversity'?
P2860
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
@ast
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
@en
type
label
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
@ast
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
@en
prefLabel
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
@ast
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
@en
P2860
P356
P1476
Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
@en
P2860
P356
10.1586/17474086.1.1.75
P577
2008-10-01T00:00:00Z